Adam Afshar
Direktor/Vorstandsmitglied bei Ariana Pharmaceuticals SA
Profil
Adam Afshar was the founder of Hyde Park Global Investments LLC, which he founded in 2005 and where he held the titles of President & Chief Executive Officer.
He is currently a Director at Ariana Pharmaceuticals SA. Mr. Afshar obtained an MBA from The University of Chicago.
Aktive Positionen von Adam Afshar
Unternehmen | Position | Beginn |
---|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | 12.11.2009 |
Ehemalige bekannte Positionen von Adam Afshar
Unternehmen | Position | Ende |
---|---|---|
Hyde Park Global Investments LLC
Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Vorstandsvorsitzender | - |
Ausbildung von Adam Afshar
The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Health Technology |
Hyde Park Global Investments LLC
Hyde Park Global Investments LLC Investment Banks/BrokersFinance Hyde Park Global Partners LLC offers a software-based investment and trading services. Its system is built primarily on genetic algorithms and other models to identify mispricing, arbitrage, and patterns in the electronic financial markets. The firm also develops robotic platform to monetize opportunities. The company was founded on May 26, 2005 and is headquartered in Atlanta, GA. | Finance |